201 related articles for article (PubMed ID: 16226510)
1. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
Kuppermann BD; Thomas EL; de Smet MD; Grillone LR;
Am J Ophthalmol; 2005 Oct; 140(4):585-97. PubMed ID: 16226510
[TBL] [Abstract][Full Text] [Related]
2. Pooled efficacy results from two multinational randomized controlled clinical trials of a single intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
Kuppermann BD; Thomas EL; de Smet MD; Grillone LR;
Am J Ophthalmol; 2005 Oct; 140(4):573-84. PubMed ID: 16125661
[TBL] [Abstract][Full Text] [Related]
3. Predicting response of vitreous hemorrhage after intravitreous injection of highly purified ovine hyaluronidase (Vitrase) in patients with diabetes.
Bhavsar AR; Grillone LR; McNamara TR; Gow JA; Hochberg AM; Pearson RK;
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4219-25. PubMed ID: 18441312
[TBL] [Abstract][Full Text] [Related]
4. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD
Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
[TBL] [Abstract][Full Text] [Related]
6. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Rosenfeld PJ; Heier JS; Hantsbarger G; Shams N
Ophthalmology; 2006 Apr; 113(4):623.e1. PubMed ID: 16581423
[TBL] [Abstract][Full Text] [Related]
7. The safety of intravitreal hyaluronidase. A clinical and histologic study.
Gottlieb JL; Antoszyk AN; Hatchell DL; Saloupis P
Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2345-52. PubMed ID: 2242999
[TBL] [Abstract][Full Text] [Related]
8. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study.
Heier JS; Antoszyk AN; Pavan PR; Leff SR; Rosenfeld PJ; Ciulla TA; Dreyer RF; Gentile RC; Sy JP; Hantsbarger G; Shams N
Ophthalmology; 2006 Apr; 113(4):633.e1-4. PubMed ID: 16483659
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronidase (Vitrase)--ISTA: hyaluronidase--ISTA pharmaceuticals.
Drugs R D; 2003; 4(3):194-7. PubMed ID: 12757408
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of hyaluronidase 75 IU as an adjuvant to mepivacaine for retrobulbar anesthesia in cataract surgery.
Remy M; Pinter F; Nentwich MM; Kampik A; Schönfeld CL
J Cataract Refract Surg; 2008 Nov; 34(11):1966-9. PubMed ID: 19006746
[TBL] [Abstract][Full Text] [Related]
12. Treatment of stage 2 macular hole by intravitreous injection of expansile gas and induction of posterior vitreous detachment.
Mori K; Saito S; Gehlbach PL; Yoneya S
Ophthalmology; 2007 Jan; 114(1):127-33. PubMed ID: 17070585
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal injection of hyaluronidase cannot induce posterior vitreous detachment in the rabbit.
Hikichi T; Kado M; Yoshida A
Retina; 2000; 20(2):195-8. PubMed ID: 10783954
[TBL] [Abstract][Full Text] [Related]
15. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
17. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.
Pieramici DJ; Rabena M; Castellarin AA; Nasir M; See R; Norton T; Sanchez A; Risard S; Avery RL
Ophthalmology; 2008 Oct; 115(10):e47-54. PubMed ID: 18708258
[TBL] [Abstract][Full Text] [Related]
18. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide in eyes with recurrent postvitrectomy diabetic vitreous hemorrhage.
Lee SY; Yoon YH; Lee HG; Chung H; Kim JG
Am J Ophthalmol; 2006 Sep; 142(3):501-3. PubMed ID: 16935603
[TBL] [Abstract][Full Text] [Related]
20. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]